Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.4.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.4.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.4.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.4.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.4.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BW.1.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BW.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BW.1.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BW.1.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BW.1.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BW.1.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BW.1.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BW.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.370EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.370EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.370ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.370ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.370EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.370EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.370ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.370ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.421EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.421EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.421ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.421ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.421EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.421EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.421ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.421ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.428.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.428.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.428.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.428.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.428.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.428.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.428.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.428.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.612EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.612EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.612ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.612ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.612EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.612EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.612ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.612ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.305EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.305EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.305ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.305ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used